GLTO Chart
See on advanced chart >
About
Galecto, Inc. was incorporated in Delaware in October 2019. The company is a clinical-stage biotechnology company developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic...
Read More
- HighlightA clinical stage biotech company focused on novel treatments for fibrosis and cancer
- ExchangeNASDAQ
- Listing Date10/29/2020
- Established DateInvalid Date
- Full-time Employees13
- Address75 State Street Suite 100 Boston Massachusetts 02109
- Tel45-70-705210
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Pharmaceuticals